Kimberly Joynt, DO
Otolaryngology · Omaha, NENPI 1427498062
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,278 of the $2,130 with a category attached, or 60.0%. 20 manufacturers reported payments, led by Medical Device Business Services, Inc. at 40.9% of the total. Reporting peaked in 2019 at $1,077 and has fallen 68.8% since, to $336 in 2025.
Across 62 payments — averaging $34.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$871
- Acclarent, Inc$219
- Aerin Medical Inc.$187
- Optinose US, Inc.$171
- Stryker$118
- Sanofi$117
- plus $447 from 14 others
What the payments were for
- Travel & lodging$82339%
- Food & beverage$1,27860%
- Other$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $871 |
| Acclarent, Inc | 7 | $219 |
| Aerin Medical Inc. | 9 | $187 |
| Optinose US, Inc. | 10 | $171 |
| Stryker | 6 | $118 |
| Sanofi | 5 | $117 |
| Smith+Nephew | 4 | $94 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Xoran Technologies LLC | 1 | $44 |
| Merck | 2 | $43 |
| Kerecis Limited | 1 | $35 |
| Inspire Medical Systems, Inc. | 2 | $32 |
| Welch Allyn | 1 | $29 |
| Intersect ENT, Inc. | 2 | $25 |
| Novartis | 1 | $22 |
| Medtronic | 1 | $20 |
| Alk-abello, Inc | 1 | $18 |
| Amgen | 1 | $15 |
| AstraZeneca | 1 | $14 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,130 in reported general payments places this provider in the 65th percentile of 86 otolaryngology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 240 | $5,645 |
| Levothyroxine Sodium | 317 | $2,328 |
| Mupirocin | 142 | $1,573 |
| Fluticasone Propionate | 112 | $1,537 |
| Omeprazole | 143 | $1,417 |
| Liothyronine Sodium | 56 | $1,273 |
| Ipratropium Bromide | 22 | $901 |
| Pantoprazole Sodium | 87 | $734 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $702 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 34 | $556 |
| Ofloxacin | 25 | $407 |
| Levocetirizine Dihydrochloride | 30 | $373 |
| Cefdinir | 18 | $314 |
| Montelukast Sodium | 51 | $313 |
| Esomeprazole Magnesium | 18 | $295 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Omaha
- Rahul VarmanOmaha$13K
- Daniel O'BrienOmaha$10K
- Wallace DuffOmaha$8K
- Tyler BlissOmaha$4K
- Adam PleasOmaha$4K
- Kyle StansiferOmaha$3K
- Jessica Moran-HansenOmaha$3K
- Jason TalmadgeOmaha$3K
- Thomas DoblemanOmaha$3K
- Stanley SchackOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.